# Identification of Sentinel Lymph Nodes Using Indocyanine Green in Breast Cancer Patients

> **NCT07311278** · NA · ACTIVE_NOT_RECRUITING · sponsor: **St. Antonius Hospital** · enrollment: 493 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Phase I: Technetium is administered as single tracer to identify the SLN (current standard).
- **PROCEDURE:** Phase II: SLN biopsy using double tracer technetium and ICG (learning curve)
- **PROCEDURE:** Phase III: ICG is administered as single tracer to identify the SLN (alternative method).

## Key facts

- **NCT ID:** NCT07311278
- **Lead sponsor:** St. Antonius Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-08
- **Primary completion:** 2025-10-30
- **Final completion:** 2026-10
- **Target enrollment:** 493 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07311278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07311278, "Identification of Sentinel Lymph Nodes Using Indocyanine Green in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07311278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*